{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:04:38Z","timestamp":1784761478321,"version":"3.55.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007481","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000}}],"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"crossref","award":["FONCyT-PICT 2015-0539"],"award-info":[{"award-number":["FONCyT-PICT 2015-0539"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"crossref","award":["FONCyT-PICT 2013-2218"],"award-info":[{"award-number":["FONCyT-PICT 2013-2218"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Council United Kingdom Global Challenges Research Fund","award":["MR\/P027989\/1"],"award-info":[{"award-number":["MR\/P027989\/1"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007481","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T13:32:51Z","timestamp":1579613571000},"page":"e0007481","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069"],"prefix":"10.1371","volume":"14","author":[{"given":"Melisa","family":"Say\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrecia","family":"Gauna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Valera-Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Reigada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana R.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7874-1894","authenticated-orcid":true,"given":"Claudio A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"pntd.0007481.ref001","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"MP Barrett","year":"2003","journal-title":"Lancet"},{"key":"pntd.0007481.ref002","first-page":"1","article-title":"Unraveling Chagas disease transmission through the oral route: Gateways to Trypanosoma cruzi infection and target tissues","author":"D Silva-dos-santos","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007481.ref003","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/B978-0-12-801029-7.00025-3","article-title":"Other forms of transmission: blood transfusion, organ transplantation, laboratory accidents, oral and sexual transmission","author":"SF Breniere","year":"2017","journal-title":"American Trypanosomiasis Chagas Disease One hundred years of research"},{"issue":"7","key":"pntd.0007481.ref004","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1590\/0074-0276140236","article-title":"Ecoepidemiology, Short history and control of chagas disease in the endemic countries and the new challenge for non-endemic countries","volume":"109","author":"JR Coura","year":"2014","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"pntd.0007481.ref005","first-page":"1","article-title":"Chagas Disease: From Discovery to a Worldwide Health Problem","volume":"7","author":"KC Freitas Lidani","year":"2019","journal-title":"Front Public Heal"},{"key":"pntd.0007481.ref006","first-page":"731","article-title":"A\u00e7o de corantes trifenil-metinicos sobre o Trypanosoma cruzi \u201cin vitro.\u201d","volume":"44","author":"V Nussenzweig","year":"1953","journal-title":"Hosp (Rio Janeiro)"},{"issue":"3","key":"pntd.0007481.ref007","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1550-7408.1995.tb01583.x","article-title":"Inhibition of Protein Synthesis and Amino Acid Transport by Crystal Violet in Trypanosoma cruzi","volume":"42","author":"M Hoffmann","year":"1995","journal-title":"J Eukaryot Microbiol"},{"issue":"6","key":"pntd.0007481.ref008","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"pntd.0007481.ref009","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jeu.12184","article-title":"Recent clinical trials for the etiological treatment of chronic chagas disease: Advances, challenges and perspectives","volume":"62","author":"JA Urbina","year":"2015","journal-title":"J Eukaryot Microbiol"},{"key":"pntd.0007481.ref010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbrc.2004.07.002","article-title":"Post genomic analysis of permeases from the amino acid\/auxin family in protozoan parasites","volume":"321","author":"A Bouvier","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"pntd.0007481.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092028","article-title":"Proline modulates the trypanosoma cruzi resistance to reactive oxygen species and drugs through a novel D, L-Proline transporter","volume":"9","author":"M Say\u00e9","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"pntd.0007481.ref012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1574-6968.2010.01936.x","article-title":"Trypanosoma cruzi amino acid transporter TcAAAP411 mediates arginine uptake in yeasts","volume":"306","author":"C Carrillo","year":"2010","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"pntd.0007481.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032760","article-title":"Cationic amino acid uptake constitutes a metabolic regulation mechanism and occurs in the flagellar pocket of trypanosoma cruzi","volume":"7","author":"MR Miranda","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"pntd.0007481.ref014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00726-010-0812-z","article-title":"Lysine transporters in human trypanosomatid pathogens","volume":"42","author":"E Inbar","year":"2012","journal-title":"Amino Acids"},{"issue":"3","key":"pntd.0007481.ref015","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbrc.2006.03.215","article-title":"Molecular and functional characterization of a spermidine transporter (TcPAT12) from Trypanosoma cruzi","volume":"344","author":"C Carrillo","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"pntd.0007481.ref016","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00232-016-9888-z","article-title":"Trypanosoma cruzi Polyamine Transporter: Its Role on Parasite Growth and Survival Under Stress Conditions","volume":"249","author":"C Reigada","year":"2016","journal-title":"J Membr Biol"},{"issue":"3","key":"pntd.0007481.ref017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0305-0491(76)90318-7","article-title":"Proline metabolism in Trypanosoma cruzi epimastigotes","volume":"55","author":"D Sylvester","year":"1976","journal-title":"Comp Biochem Physiol\u2014Part B Biochem"},{"key":"pntd.0007481.ref018","first-page":"219","article-title":"Regulatory volume decrease in Trypanosoma cruzi involves amino acid efflux and changes in intracellular calcium","volume":"126","author":"P Rohloff","year":"2003","journal-title":"Science"},{"issue":"7","key":"pntd.0007481.ref019","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1128\/IAI.00138-09","article-title":"Use of L-proline and ATP production by Trypanosoma cruzi metacyclic forms as requirements for host cell invasion","volume":"77","author":"RM Martins","year":"2009","journal-title":"Infect Immun"},{"issue":"8","key":"pntd.0007481.ref020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1462-5822.2004.00397.x","article-title":"L-Proline is essential for the intracellular differentiation of Trypanosoma cruzi","volume":"6","author":"R Tonelli","year":"2004","journal-title":"Cell Microbiol"},{"key":"pntd.0007481.ref021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/BJ20140719","article-title":"Trypanosoma brucei eflornithine transporter AAT6 is a low affinity, low selective transporter for neutral amino acids","volume":"18","author":"C Mathieu","year":"2014","journal-title":"Biochem J"},{"issue":"11","key":"pntd.0007481.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1001204","article-title":"A molecular mechanism for eflornithine resistance in African trypanosomes","volume":"6","author":"IM Vincent","year":"2010","journal-title":"PLoS Pathog"},{"key":"pntd.0007481.ref023","first-page":"1","article-title":"Arginine and lysine transporters are essential for Trypanosoma brucei","author":"C Mathieu","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"pntd.0007481.ref024","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/BJ20121262","article-title":"A versatile proline\/alanine transporter in the unicellular pathogen Leishmania donovani regulates amino acid homoeostasis and osmotic stress responses","volume":"449","author":"E Inbar","year":"2013","journal-title":"Biochem J"},{"key":"pntd.0007481.ref025","doi-asserted-by":"crossref","first-page":"16289","DOI":"10.1038\/srep16289","article-title":"Size does matter: 18 amino acids at the N-terminal tip of an amino acid transporter in Leishmania determine substrate specificity","volume":"5","author":"D Schlisselberg","year":"2015","journal-title":"Sci Rep"},{"key":"pntd.0007481.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2018.04.002","article-title":"Stage-specific expression of the proline-alanine transporter in the human pathogen Leishmania","volume":"222","author":"T Liburkin-Dan","year":"2018","journal-title":"Mol Biochem Parasitol"},{"issue":"4","key":"pntd.0007481.ref027","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/jeu.12295","article-title":"Trypanosoma cruzi Proline Transport Presents a Cell Density-dependent Regulation","volume":"63","author":"M Say\u00e9","year":"2016","journal-title":"J Eukaryot Microbiol"},{"issue":"11","key":"pntd.0007481.ref028","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.bbagen.2017.08.015","article-title":"Evaluation of proline analogs as trypanocidal agents through the inhibition of a Trypanosoma cruzi proline transporter","volume":"1861","author":"M Say\u00e9","year":"2017","journal-title":"Biochim Biophys Acta\u2014Gen Subj"},{"issue":"8","key":"pntd.0007481.ref029","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"TT Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"pntd.0007481.ref030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"KT Andrews","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"3","key":"pntd.0007481.ref031","first-page":"93","article-title":"Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media","volume":"6","author":"E Camargo","year":"1964","journal-title":"Rev Inst Med S\u00e3o Paulo"},{"issue":"2","key":"pntd.0007481.ref032","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0378-1119(99)00386-8","article-title":"Functional analysis of the intergenic regions of TcP2B gene loci allowed the construction of an improved Trypanosoma cruzi expression vector","volume":"239","author":"MP Vazquez","year":"1999","journal-title":"Gene"},{"issue":"10","key":"pntd.0007481.ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0080217","article-title":"Plasmid Vectors and Molecular Building Blocks for the Development of Genetic Manipulation Tools for Trypanosoma cruzi","volume":"8","author":"LA Bouvier","year":"2013","journal-title":"PLoS One"},{"issue":"1\u20132","key":"pntd.0007481.ref034","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-5793(03)01171-2","article-title":"Arginine kinase overexpression improves Trypanosoma cruzi survival capability","volume":"554","author":"C a Pereira","year":"2003","journal-title":"FEBS Lett"},{"issue":"6","key":"pntd.0007481.ref035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1550-7408.1999.tb05132.x","article-title":"L-arginine uptake and L-phosphoarginine synthesis in Trypanosoma cruzi","volume":"46","author":"CA Pereira","year":"1999","journal-title":"J Eukaryot Microbiol"},{"issue":"3","key":"pntd.0007481.ref036","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.actatropica.2011.08.011","article-title":"The heme uptake process in Trypanosoma cruzi epimastigotes is inhibited by heme analogues and by inhibitors of ABC transporters","volume":"120","author":"MP Cupello","year":"2011","journal-title":"Acta Trop"},{"key":"pntd.0007481.ref037","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molbiopara.2018.07.007","article-title":"L-Glutamine uptake is developmentally regulated and is involved in metacyclogenesis in Trypanosoma cruzi","volume":"224","author":"FS Damasceno","year":"2018","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"pntd.0007481.ref038","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0003-2697(86)90314-3","article-title":"Determination of cell number in monolayer cultures","volume":"159","author":"RJ Gillies","year":"1986","journal-title":"Anal Biochem"},{"issue":"11","key":"pntd.0007481.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0079568","article-title":"SWEETLEAD: An in silico database of approved drugs, regulated chemicals, and herbal isolates for computer-aided drug discovery","volume":"8","author":"PA Novick","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"pntd.0007481.ref040","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/acs.jcim.5b00136","article-title":"LiSiCA: A Software for Ligand-Based Virtual Screening and Its Application for the Discovery of Butyrylcholinesterase Inhibitors","volume":"55","author":"S Lesnik","year":"2015","journal-title":"J Chem Inf Model"},{"issue":"8","key":"pntd.0007481.ref041","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1021\/ci2001023","article-title":"Build-up algorithm for atomic correspondence between chemical structures","volume":"51","author":"T Kawabata","year":"2011","journal-title":"J Chem Inf Model"},{"issue":"2","key":"pntd.0007481.ref042","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/ci800315d","article-title":"ShaEP: Molecular overlay based on shape and electrostatic potential","volume":"49","author":"MJ Vainio","year":"2009","journal-title":"J Chem Inf Model"},{"key":"pntd.0007481.ref043","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K","article-title":"A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape","volume":"17","author":"JA Grant","year":"1996","journal-title":"Journal of Computational Chemistry"},{"issue":"W1","key":"pntd.0007481.ref044","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkv342","article-title":"I-TASSER server: New development for protein structure and function predictions","volume":"43","author":"J Yang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"pntd.0007481.ref045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0076-6879(03)74020-8","article-title":"MODELLER: Generation and Refinement of Homology-Based Protein Structure Models","volume":"374","author":"A Fiser","year":"2003","journal-title":"Methods in Enzymology"},{"issue":"16","key":"pntd.0007481.ref046","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"GM Morris","year":"2009","journal-title":"J Comput Chem"},{"issue":"1","key":"pntd.0007481.ref047","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"G Wolber","year":"2005","journal-title":"J Chem Inf Model"},{"issue":"2","key":"pntd.0007481.ref048","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0022-5193(76)90169-7","article-title":"Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands","volume":"59","author":"TC Chou","year":"1976","journal-title":"J Theor Biol"},{"issue":"C","key":"pntd.0007481.ref049","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"pntd.0007481.ref050","article-title":"Active Transport of L-Proline in Trypanosoma cruzi","volume":"9","author":"AM Silber","year":"2002","journal-title":"J Eukaryot Microbiol"},{"issue":"7","key":"pntd.0007481.ref051","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1590\/S0074-02762010000700014","article-title":"Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease","volume":"105","author":"M Moreno","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"pntd.0007481.ref052","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.meegid.2011.12.009","article-title":"The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications","volume":"12","author":"B Zingales","year":"2012","journal-title":"Infect Genet Evol"},{"issue":"14","key":"pntd.0007481.ref053","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized Trial of Benznidazole for Chronic Chagas\u2019 Cardiomyopathy","volume":"373","author":"CA Morillo","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"pntd.0007481.ref054","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. cruzi Carriers","volume":"69","author":"C Morillo","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"pntd.0007481.ref055","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.00689-15","article-title":"Antitrypanosomal treatment with benznidazole is superior to posaconazole regimens in mouse models of Chagas disease","volume":"59","author":"S Khare","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0007481.ref056","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease","volume":"370","author":"I Molina","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"pntd.0007481.ref057","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10822-016-9903-6","article-title":"Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning","volume":"30","author":"LN Alberca","year":"2016","journal-title":"J Comput Aided Mol Des"},{"key":"pntd.0007481.ref058","first-page":"1","article-title":"Trypanocidal effect of isotretinoin through the inhibition of polyamine and amino acid transporters in Trypanosoma cruzi","author":"C Reigada","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007481.ref059","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2018.02.006","article-title":"Identification of cisapride as new inhibitor of putrescine uptake in Trypanosoma cruzi by combined ligand- and structure-based virtual screening","volume":"149","author":"RC Dietrich","year":"2018","journal-title":"Eur J Med Chem"},{"key":"pntd.0007481.ref060","first-page":"4","article-title":"Actions of a proline analogue, L-thiazolidine-4-carboxylic acid (T4C), on Trypanosoma cruzi","author":"A Magdaleno","year":"2009","journal-title":"PLoS One"},{"issue":"9","key":"pntd.0007481.ref061","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/ci400284v","article-title":"Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: Discovery of amiodarone and bromocriptine inhibitory effects","volume":"53","author":"CL Bellera","year":"2013","journal-title":"J Chem Inf Model"},{"key":"pntd.0007481.ref062","first-page":"2014","article-title":"Identification of levothyroxine antichagasic activity through computer-aided drug repurposing","author":"CL Bellera","year":"2014","journal-title":"Sci World J"},{"issue":"1","key":"pntd.0007481.ref063","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijantimicag.2016.02.018","article-title":"Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease","volume":"48","author":"ML Sbaraglini","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"pntd.0007481.ref064","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22061015","article-title":"Repositioning FDA drugs as potential cruzain inhibitors from Trypanosoma cruzi: Virtual screening, in vitro and in vivo studies","volume":"22","author":"I Palos","year":"2017","journal-title":"Molecules"},{"issue":"8","key":"pntd.0007481.ref065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0001297","article-title":"The susceptibility of trypanosomatid pathogens to PI3\/mTOR kinase inhibitors affords a new opportunity for drug repurposing","volume":"5","author":"R Diaz-Gonzalez","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0007481.ref066","first-page":"655","article-title":"Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery","author":"G Patel","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"pntd.0007481.ref067","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/acsinfecdis.5b00136","article-title":"Identification of \u201cpreferred\u201d Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?","volume":"2","author":"E Amata","year":"2016","journal-title":"ACS Infect Dis"},{"key":"pntd.0007481.ref068","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejmech.2017.03.063","article-title":"An in vitro and in vivo evaluation of new potential trans-sialidase inhibitors of Trypanosoma cruzi predicted by a computational drug repositioning method","volume":"132","author":"EE Lara-Ramirez","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"7","key":"pntd.0007481.ref069","doi-asserted-by":"crossref","first-page":"e2977","DOI":"10.1371\/journal.pntd.0002977","article-title":"Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi","volume":"8","author":"JD Planer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"pntd.0007481.ref070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0135556","article-title":"Antiprotozoal activity profiling of approved drugs: A starting point toward drug repositioning","volume":"10","author":"M Kaiser","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"pntd.0007481.ref071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004584","article-title":"Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade","volume":"10","author":"M De Rycker","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"pntd.0007481.ref072","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijantimicag.2016.06.024","article-title":"HIV aspartic peptidase inhibitors are effective drugs against the trypomastigote form of the human pathogen Trypanosoma cruzi","volume":"48","author":"LS Sangenito","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"pntd.0007481.ref073","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijantimicag.2016.09.017","article-title":"Nelfinavir and lopinavir impair Trypanosoma cruzi trypomastigote infection in mammalian host cells and show anti-amastigote activity","volume":"48","author":"LS Sangenito","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"pntd.0007481.ref074","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcp.2017.08.025","article-title":"Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy","volume":"145","author":"MR Sim\u00f5es-Silva","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"pntd.0007481.ref075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.actatropica.2014.05.017","article-title":"Histamine H1-receptor antagonists against Leishmania (L.) infantum: An in vitro and in vivo evaluation using phosphatidylserine-liposomes","volume":"137","author":"EG Pinto","year":"2014","journal-title":"Acta Trop"},{"key":"pntd.0007481.ref076","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0304-4017(95)00856-X","article-title":"Trypanocidal resistance in Trypanosoma evansi in vitro: Effects of verapamil, cyproheptidine, desipramine and chlorpromazine alone and in combination with trypanocides","volume":"62","author":"BM Anene","year":"1996","journal-title":"Vet Parasitol"},{"issue":"2","key":"pntd.0007481.ref077","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00406-013-0413-4","article-title":"Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate","volume":"264","author":"G Fond","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"pntd.0007481.ref078","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejmech.2015.01.065","article-title":"Computer-guided drug repurposing: Identification of trypanocidal activity of clofazimine, benidipine and saquinavir","volume":"93","author":"CL Bellera","year":"2015","journal-title":"Eur J Med Chem"},{"key":"pntd.0007481.ref079","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.actatropica.2017.09.017","article-title":"Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity","volume":"184","author":"B Zingales","year":"2017","journal-title":"Acta Trop"},{"issue":"1\u20132","key":"pntd.0007481.ref080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches","volume":"115","author":"JA Urbina","year":"2010","journal-title":"Acta Trop"},{"issue":"3","key":"pntd.0007481.ref081","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies","volume":"58","author":"TC Chou","year":"2006","journal-title":"Pharmacol Rev"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007481","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T13:35:24Z","timestamp":1580477724000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007481"}},"subtitle":[],"editor":[{"given":"Igor C.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007481","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/645333","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,21]]}}}